chr10-113849181-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014881.5(DCLRE1A):āc.1924A>Gā(p.Asn642Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_014881.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCLRE1A | NM_014881.5 | c.1924A>G | p.Asn642Asp | missense_variant | 2/9 | ENST00000361384.7 | NP_055696.3 | |
DCLRE1A | NM_001271816.2 | c.1924A>G | p.Asn642Asp | missense_variant | 3/10 | NP_001258745.1 | ||
DCLRE1A | XM_006718090.2 | c.1924A>G | p.Asn642Asp | missense_variant | 3/10 | XP_006718153.1 | ||
DCLRE1A | XM_011540429.2 | c.1924A>G | p.Asn642Asp | missense_variant | 3/10 | XP_011538731.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCLRE1A | ENST00000361384.7 | c.1924A>G | p.Asn642Asp | missense_variant | 2/9 | 1 | NM_014881.5 | ENSP00000355185 | P1 | |
ENST00000692647.1 | n.139-3444T>C | intron_variant, non_coding_transcript_variant | ||||||||
DCLRE1A | ENST00000369305.1 | c.1924A>G | p.Asn642Asp | missense_variant | 3/10 | 5 | ENSP00000358311 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461722Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727154
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at